171 related articles for article (PubMed ID: 29772386)
1. Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.
Bao N; Ou J; Li N; Zou P; Sun J; Chen L
Eur J Med Chem; 2018 Jun; 154():1-8. PubMed ID: 29772386
[TBL] [Abstract][Full Text] [Related]
2. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
3. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
Tripathi SK; Rengasamy KRR; Biswal BK
Arch Pharm Res; 2020 Feb; 43(2):242-256. PubMed ID: 32034669
[TBL] [Abstract][Full Text] [Related]
5. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
6. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
7. The natural anticancer agent plumbagin induces potent cytotoxicity in MCF-7 human breast cancer cells by inhibiting a PI-5 kinase for ROS generation.
Lee JH; Yeon JH; Kim H; Roh W; Chae J; Park HO; Kim DM
PLoS One; 2012; 7(9):e45023. PubMed ID: 23028742
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
Li N; Ou J; Bao N; Chen C; Shi Z; Chen L; Sun J
Bioorg Chem; 2020 Nov; 104():104208. PubMed ID: 32919131
[TBL] [Abstract][Full Text] [Related]
9. Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
Fiorito S; Genovese S; Taddeo VA; Mathieu V; Kiss R; Epifano F
Bioorg Med Chem Lett; 2016 Jan; 26(2):334-337. PubMed ID: 26706169
[TBL] [Abstract][Full Text] [Related]
10. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
[TBL] [Abstract][Full Text] [Related]
11. NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells.
Liu L; Li T; Tan J; Fu J; Guo Q; Ji H; Zhang Y
Int Immunopharmacol; 2014 Nov; 23(1):27-36. PubMed ID: 25135879
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells.
Sagar S; Esau L; Moosa B; Khashab NM; Bajic VB; Kaur M
Anticancer Agents Med Chem; 2014 Jan; 14(1):170-80. PubMed ID: 24164046
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
Mallavadhani UV; Prasad CV; Shrivastava S; Naidu VG
Eur J Med Chem; 2014 Aug; 83():84-91. PubMed ID: 24953027
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
18. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
19. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
20. NG, a novel PABA/NO-based oleanolic acid derivative, induces human hepatoma cell apoptosis via a ROS/MAPK-dependent mitochondrial pathway.
Liu L; Fu J; Li T; Cui R; Ling J; Yu X; Ji H; Zhang Y
Eur J Pharmacol; 2012 Sep; 691(1-3):61-8. PubMed ID: 22824464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]